167 related articles for article (PubMed ID: 33978602)
1. Impact of Vaginal Estrogen on the Urobiome in Postmenopausal Women With Recurrent Urinary Tract Infection.
Jung CE; Estaki M; Chopyk J; Taylor BC; Gonzalez A; McDonald D; Shin J; Ferrante K; Wasenda E; Lippmann Q; Knight R; Pride D; Lukacz ES
Female Pelvic Med Reconstr Surg; 2022 Jan; 28(1):20-26. PubMed ID: 33978602
[TBL] [Abstract][Full Text] [Related]
2. Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome.
Neugent ML; Kumar A; Hulyalkar NV; Lutz KC; Nguyen VH; Fuentes JL; Zhang C; Nguyen A; Sharon BM; Kuprasertkul A; Arute AP; Ebrahimzadeh T; Natesan N; Xing C; Shulaev V; Li Q; Zimmern PE; Palmer KL; De Nisco NJ
Cell Rep Med; 2022 Oct; 3(10):100753. PubMed ID: 36182683
[TBL] [Abstract][Full Text] [Related]
3. The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections.
Anglim B; Phillips C; Shynlova O; Alarab M
Int Urogynecol J; 2022 Aug; 33(8):2107-2117. PubMed ID: 34003309
[TBL] [Abstract][Full Text] [Related]
4. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms.
Thomas-White K; Taege S; Limeira R; Brincat C; Joyce C; Hilt EE; Mac-Daniel L; Radek KA; Brubaker L; Mueller ER; Wolfe AJ
Am J Obstet Gynecol; 2020 Nov; 223(5):727.e1-727.e11. PubMed ID: 32791124
[TBL] [Abstract][Full Text] [Related]
5. Vaginal Microbiome of Pregnant Indian Women: Insights into the Genome of Dominant Lactobacillus Species.
Mehta O; Ghosh TS; Kothidar A; Gowtham MR; Mitra R; Kshetrapal P; Wadhwa N; Thiruvengadam R; ; Nair GB; Bhatnagar S; Das B
Microb Ecol; 2020 Aug; 80(2):487-499. PubMed ID: 32206831
[TBL] [Abstract][Full Text] [Related]
6. The Urinary Microbiome in Postmenopausal Women with Recurrent Urinary Tract Infections.
Vaughan MH; Mao J; Karstens LA; Ma L; Amundsen CL; Schmader KE; Siddiqui NY
J Urol; 2021 Nov; 206(5):1222-1231. PubMed ID: 34181466
[TBL] [Abstract][Full Text] [Related]
7. Urinary microbiome community types associated with urinary incontinence severity in women.
Carnes MU; Siddiqui NY; Karstens L; Gantz MG; Dinwiddie DL; Sung VW; Bradley M; Brubaker L; Ferrando CA; Mazloomdoost D; Richter HE; Rogers RG; Smith AL; Komesu YM;
Am J Obstet Gynecol; 2024 Mar; 230(3):344.e1-344.e20. PubMed ID: 38937257
[TBL] [Abstract][Full Text] [Related]
8. Reproductive tract microbiota of women in childbearing age shifts upon gynecological infections and menstrual cycle.
Cheng L; Gao Y; Xia Q; Wang H; Xie X; Liu Y; Shang H; Diao Y
BMC Microbiol; 2021 Sep; 21(1):252. PubMed ID: 34548031
[TBL] [Abstract][Full Text] [Related]
9. Urine and vaginal microbiota compositions of postmenopausal and premenopausal women differ regardless of recurrent urinary tract infection and renal transplant status.
Hugenholtz F; van der Veer C; Terpstra ML; Borgdorff H; van Houdt R; Bruisten S; Geerlings SE; van de Wijgert JHHM
Sci Rep; 2022 Feb; 12(1):2698. PubMed ID: 35177690
[TBL] [Abstract][Full Text] [Related]
10. Defining the relationship between vaginal and urinary microbiomes.
Komesu YM; Dinwiddie DL; Richter HE; Lukacz ES; Sung VW; Siddiqui NY; Zyczynski HM; Ridgeway B; Rogers RG; Arya LA; Mazloomdoost D; Levy J; Carper B; Gantz MG;
Am J Obstet Gynecol; 2020 Feb; 222(2):154.e1-154.e10. PubMed ID: 31421123
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Concordance Between Urogenital and Vaginal Microbiota: Can Urine Specimens Be Used as a Proxy for Vaginal Samples?
Brown SE; Robinson CK; Shardell MD; Holm JB; Ravel J; Ghanem KG; Brotman RM
Front Cell Infect Microbiol; 2021; 11():671413. PubMed ID: 34268137
[TBL] [Abstract][Full Text] [Related]
12. The Vaginal Microbial Signatures of Preterm Birth Delivery in Indian Women.
Kumar S; Kumari N; Talukdar D; Kothidar A; Sarkar M; Mehta O; Kshetrapal P; Wadhwa N; Thiruvengadam R; Desiraju BK; Nair GB; Bhatnagar S; Mukherjee S; Das B;
Front Cell Infect Microbiol; 2021; 11():622474. PubMed ID: 34094994
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Local Estrogen on the Urogenital Microbiome in Genitourinary Syndrome of Menopause: A Randomized-Controlled Trial.
Lillemon JN; Karstens L; Nardos R; Garg B; Boniface ER; Gregory WT
Female Pelvic Med Reconstr Surg; 2022 Jun; 28(6):e157-e162. PubMed ID: 35420551
[TBL] [Abstract][Full Text] [Related]
14. Can the composition of the intestinal microbiota predict the development of urinary tract infections?
den Heijer CD; Geerlings SE; Prins JM; Beerepoot MA; Stobberingh EE; Penders J
Future Microbiol; 2016 Oct; 11():1395-1404. PubMed ID: 27785923
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and Research Insights From a Randomized Controlled Trial for Recurrent Urinary Tract Infection Prevention in Postmenopausal Women Using Vaginal Estrogen Therapy.
Lenger SM; Chu CM; Ghetti C; Durkin MJ; Jennings Z; Sutcliffe S; Lowder JL
Female Pelvic Med Reconstr Surg; 2022 Jun; 28(6):e163-e170. PubMed ID: 35421017
[TBL] [Abstract][Full Text] [Related]
16. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials.
Chen YY; Su TH; Lau HH
Int Urogynecol J; 2021 Jan; 32(1):17-25. PubMed ID: 32564121
[TBL] [Abstract][Full Text] [Related]
17. Influence of Lactobacillus crispatus, Lactobacillus iners and Gardnerella vaginalis on bacterial vaginal composition in pregnant women.
Witkin SS; Moron AF; Linhares IM; Forney LJ
Arch Gynecol Obstet; 2021 Aug; 304(2):395-400. PubMed ID: 33521838
[TBL] [Abstract][Full Text] [Related]
18. Association between vaginal microbiota and vaginal inflammatory immune markers in postmenopausal women.
Byrne EH; Song H; Srinivasan S; Fredricks DN; Reed SD; Guthrie KA; Wu M; Mitchell CM
Menopause; 2024 Jul; 31(7):575-581. PubMed ID: 38713891
[TBL] [Abstract][Full Text] [Related]
19. The etiology and management of recurrent urinary tract infections in postmenopausal women.
Jung C; Brubaker L
Climacteric; 2019 Jun; 22(3):242-249. PubMed ID: 30624087
[TBL] [Abstract][Full Text] [Related]
20. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.
Stapleton AE; Au-Yeung M; Hooton TM; Fredricks DN; Roberts PL; Czaja CA; Yarova-Yarovaya Y; Fiedler T; Cox M; Stamm WE
Clin Infect Dis; 2011 May; 52(10):1212-7. PubMed ID: 21498386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
